Page 4 - Trial Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Expected Today - Breaking & Trending Today

Capricor Therapeutics Reports First Quarter 2021

Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 16:05 ET
| Source:
Capricor Therapeutics
Capricor Therapeutics

-Data for Phase II INSPIRE Clinical Trial Expected in Third Quarter-
-Plan to File IND for Multivalent Exosome-mRNA Vaccine for SARS-CoV-2 in Third Quarter-
-To Host Conference Call and Webcast Today at 4:30 p.m. ET-

LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today reported its financial results for the first quarter ended March 31, 2021, and provided an overview of its recent operational highlights. Management will host a webcast and conference call at 4:30 p.m. today after market. ....

United States , Linda Marb , Johns Hopkins University , Capricor Therapeutics Inc , American Society Of Gene , International Society For Extracellular Vesicles , Requested Meeting , Discuss Next Steps , Duchenne Muscular , Trial Expected , Webcast Today , Recent Corporate Developments , American Society , Cell Therapy , International Society , Extracellular Vesicles , First Quarter , ஒன்றுபட்டது மாநிலங்களில் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , அமெரிக்கன் சமூகம் ஆஃப் கீந் , சோதனை எதிர்பார்க்கப்படுகிறது , சமீப பெருநிறுவன முன்னேற்றங்கள் , அமெரிக்கன் சமூகம் , செல் சிகிச்சை , சர்வதேச சமூகம் , முதல் காலாண்டு ,

Allogene Therapeutics Receives IND Clearance from the U.S. Food and Drug Administration for ALLO-715 in Combination with Nirogacestat in Relapsed/Refractory Multiple Myeloma – IT Business Net

Allogene Therapeutics Receives IND Clearance from the U.S. Food and Drug Administration for ALLO-715 in Combination with Nirogacestat in Relapsed/Refractory Multiple Myeloma – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Christine Cassiano , Rafael Amado , Allogene Therapeutics Inc , European Commission , Drug Administration , Research Development , American Society Of Hematology , Us Food Drug Administration , Combination Represents One , Three Strategies , Trial Expected , First Quarter , Allogene Therapeutics , Investigational New Drug , Springworks Therapeutic , Executive Vice President , Chief Medical Officer , American Society , Orphan Drug Designation , Fast Track , Breakthrough Therapy Designations , South San Francisco , Private Securities Litigation Reform Act , Investor Contact , Genetics Home Reference ,